May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Autologous Serum Application for the Management of Recurrent Corneal Erosions
Author Affiliations & Notes
  • N.G. Ziakas
    Dept of Ophthalmology, Ahepa Hospital Aristotelean Univ, Thessaloniki, Greece
  • N.S. Georgiadis
    Dept of Ophthalmology, Ahepa Hospital Aristotelean Univ, Thessaloniki, Greece
  • K.G. Boboridis
    Dept of Ophthalmology, Ahepa Hospital Aristotelean Univ, Thessaloniki, Greece
  • D.G. Mikropoulos
    Dept of Ophthalmology, Ahepa Hospital Aristotelean Univ, Thessaloniki, Greece
  • Footnotes
    Commercial Relationships  N.G. Ziakas, None; N.S. Georgiadis, None; K.G. Boboridis, None; D.G. Mikropoulos, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1380. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      N.G. Ziakas, N.S. Georgiadis, K.G. Boboridis, D.G. Mikropoulos; Autologous Serum Application for the Management of Recurrent Corneal Erosions . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1380.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the use of autologous serum for the treatment of recurrent corneal erosions Methods: Retrospective study of 21 consecutive patients to whom autologous serum was prescribed for recurrent corneal erosions. Various other treatment modalities including artificial tears, ointments, bandage contact lenses and anterior stoma punctures, had already been used in all patients who already have been symptomatic for over 18 months. Autologous serum was prescribed for 6 months in a 6 times daily dosage for the first 3 months reduced to 4 times daily for the remaining 3 month period Results: The follow-up period ranged from 12 to 48 months. None of the patients had recurrence while under treatment. In 2 patients a recurrence occurred in the follow up period while the other 19 remained symptom free throughout the follow up period Conclusions: Autologous serum was proven to be an effective treatment modality for the treatment of recurrent corneal erosions

Keywords: cornea: epithelium • clinical (human) or epidemiologic studies: out • clinical (human) or epidemiologic studies: tre 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×